Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

NCT07829081 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT07829081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07829081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2026
Completion date
August 31, 2033
Enrollment
234 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

microsatellite instability-high colorectal cancer, microsatellite instability-high gastroesophageal adenocarcinoma, microsatellite instability-high rectal cancer, mismatch repair deficient colorectal cancer, mismatch repair- deficient rectal cancer, mismatch repair-deficient colon cancer, mismatch repair-deficient gastric cancer, mismatch repair-deficient gastroesophageal adenocarcinoma, quality of life (qol), stage ii colorectal cancer, stage iii colorectal cancer